HIV type 2 in New York City, 2000-2008

Clinical Infectious Diseases

Volumn 51, Issue 11, 2010, Pages 1334-1342

  Torian, Lucia V ^a   Eavey, Joanna J ^a   Punsalang, Amado P ^a   Pirillo, Robert E ^a   Forgione, Lisa A ^a   Kent, Scott A ^a   Oleszko, William R ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; VIRUS LOAD; WESTERN BLOTTING;

ADOLESCENT; ADULT; AFRICA, WESTERN; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-2; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW YORK CITY; YOUNG ADULT;

EID: 78649900218     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/657117     Document Type: Article

References (40)

1. Clavel F, Guetard D, Brun V, et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986; 233:343-346.
2. Kanki PJ. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science 1986; 232:238-243.
3. Kanki PJ, DeCock K. Epidemiology and natural history of HIV-2. In: DeVita VJ, Hellman S, Rosenberg SA, eds. AIDS: etiology, diagnosis, treatment, and prevention. Philadelphia, PA: JB Lippincott, 1997: 127-135.
4. Kanki PJ. Human immunodeficiency virus type 2 (HIV-2). AIDS Rev 1999; 1:101-108.
5. Kanki PJ, Travers KU, M'Boup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343:943-946. (Pubitemid 24117229)
6. Matheron S. Vertical transmission of HIV-2. Lancet 1990; 335:1103-1104.
7. Andreasson P, Dias F, Naucler A, Anderson S, Biberfeld G. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 1993; 7:989.
8. Adjorlolo-Johnson G, DeCock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994; 272:462-466.
9. O'Donovan D, Ariyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. AIDS 2000; 14:441-448. (Pubitemid 30182442)
10. Padua E, Almeida C, Nunes B, et al. Assessment of mother-to-child HIV-1 and HIV-2 transmission: an AIDS reference laboratory collaborative study. HIV Med 2009; 10(3:)182-190.
11. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-1590.
12. Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol 2002; 83:1253-1265.
13. Mullins C, Eisen G, Popper S, et al. Highly active antiretroviral therapy and viral response in HIV type 2 infection. Clin Infect Dis 2004; 38:1771-1779.
14. Zheng NN, McElrath MJ, Sow PS, et al. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. J Virol 2007; 81(17):9061-9071.
15. Leligdowicz A, Rowland-Jones S. Tenets of protection fromprogression to AIDS: lessons from the immune responses to HIV-2 infection. Expert Rev Vaccines 2008; 7(3):319-331. (Pubitemid 351520020)
16. Poulsen A-G, Aaby P, Larsen O, et al. Nine-year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet 1997; 349:911-914.
17. Berry N, Jaffar S, Schim van der Loeff M, et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV-2-infected villagers. AIDS Res Hum Retroviruses 2002; 18:1167-1173.
18. Popper SJ, Sarr AD, Travers KU, et al. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J Infect Dis 1999; 180:1116-1121.
19. Duvall MG, Jaye A, Dong T, et al. Maintenance of HIV-2 specific CD4+ T-cell help distinguishes HIV-2 from HIV-1 infection. J Immunol 2006; 176:6973-6981.
20. Mikhail M, Wang B, Lemey P, et al. Role of viral evolutionary rate in disease progression in a linked cohort. Retrovirology 2005; 2:41.
21. Popper SJ, Sarr AD, Gueye-Ndiaye A, M'Boup S, Essex ME, Kanki PJ. Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: low virus production in vivo. J Virol 2000; 74:1554-1557. (Pubitemid 30044108)
22. MacNeil A, Sankale J-L, Meloni ST, Sarr AD, m'Boup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. J Infect Dis 2007; 195:726-733.
23. Berry N, Ariyoshi K, Jaffar S, et al. Low peripheral blood viral HIV-2 RNA in dividuals with high CD4 percentage differentiates HIV-2 from HIV-1. J Hum Virol 1998; 1(7):457-468. (Pubitemid 128543591)
24. Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000; 160:3286-3293.
25. New York City Department of Health and Mental Hygiene, HIV Epidemiology and Field Services Program. HIV diagnoses in New York City by region of birth and UHF neighborhood, 2001-2006. Semi-annual Report 3;1:3, April 2008.
26. New York City Department of Health and Mental Hygiene, HIV Epidemiology and Field Services Program. HIV/AIDS in foreign-born New Yorkers, 2007. http://www.nyc.gov/html/doh/html/dires/hivepi.shtml. Accessed 2 August 2010.
27. Kerani, RP, Kent JB, Sides T, et al. HIV epidemic among African-born persons in the United States: a hidden epidemic? J Acquir Immune Defic Syndr 2008; 49(1):102-106.
28. Weisfuse IB, Chiasson MA, Punsalang A, Oleszko W, Lawrence K, Beatrice S. HIV-2 infection in New York City [abstract 82]. In: Program and abstracts of the First National Conference on Human Retroviruses and Related Infections, Washington, DC, 12-16 December 1993.
29. Beatrice ST, Oleszko WR, Torian LV, Chiasson MA, Punsalang A, Weisfuse IB, Schable CA. Detection of HIV-2 in specimens submitted for HIV-1 testing in New York City from 1993-1995 [abstract 113]. In: Program and abstracts of the 5th Conference on Human Retroviruses and Related Infections, Chicago, Illinois, 1-5 February 1998.
30. State of New York, Public Health Law Article 21 (1983), Public Health Law Article 27-F- HIV and AIDS Information; Public Health Law Article 21, Title III - HIV Reporting and Partner Notification (1998); Code of Administrative Rules and Regulations, Title 10 Part 63 (2000).
31. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-1/HTLV-II. Wkly Epidemiol Rec 1990; 65:281-283.
32. Varnier OI, Lillo FB, Schito GC, Lazzarin A, Kanki PJ. Parallel western blot analysis for HIV-1 and HIV-2 antiboies: absence of HIV-2 infection in Italian subjects at risk for AIDS. AIDS 1988; 2(3):215-217.
33. DeCock KM, Porter A, Kouadio J, et al. Cross-reactivity on Western blots in HIV-1 and HIV-2 infections. AIDS 1991; 5(7):859-863.
34. Dieng-Sarr A, Saltier de la Tour, Diallo AA, et al. HIV-2 western blot profiles in Senegal: cross-reactivity and evaluation of the WHO interpretation criteria [abstract PoC 4431]. In: Program and abstracts of the VIII International Conference on AIDS, Amsterdam, the Netherlands, 19-24 July 1992.
35. Rae FM, Healey DS, Best SJ, Dax EM. Characterisation of HIV-2 western blot reactivity [abstract PO-A31-0759]. In: Program and abstracts of the IX International Conference on AIDS, Berlin, Germany, 6-11 June 1993.
36. Kline RL, McNairn D, Holodniy M, et al. Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay. J Clin Microbiol 1996; 34(11):2650-2653.
37. Heridia A, Kumar U, Soriano V, Gutierrez M, Hewlett I, Epstein J. PCR strategies for diagnosis of HIV-2 infection [PO-A34-0812]. In: Program and abstracts of the IX International Conference on AIDS, Berlin, Germany, 6-11 June 1993.
38. New York City Department of Health and Mental Hygiene, DOHMH Health Advisory #28, July 20, 2009. Diagnostic testing for HIV-2. https://a816- healthpsi.nyc.gov/han/nychan/Documents/AlertsAdvisoriesUpdates/HIV2AIDS/ FAQHIV-220July%2009.pdf. Accessed 2 August 2010.
39. Association of Public Health Laboratories, HIV testing algorithms: A status report. http://www.aphl.org/hiv/statusreport. Accessed 4 August 2010.
40. Pandori MW, Branson BM. 2010 HIV diagnostics conference. Expert Rev Anti Infect Ther 2010; 8(6):631-633.